Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. - PE Ratioverified

ELDN

Price:

$3.92

Market Cap:

$235.00M

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address type 1 diabetes. Previously known as Novus Therapeutics, Inc., the company adopted its current name, El...[Read more]

Industry

Biotechnology

IPO Date

2014-09-17

Stock Exchange

NASDAQ

Ticker

ELDN

The PE Ratio as of June 2026 (TTM) for Eledon Pharmaceuticals, Inc. (ELDN) is -5.09

According to Eledon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.09. This represents a change of 66.50% compared to the average of -3.06 of the last 4 quarters.

Eledon Pharmaceuticals, Inc. (ELDN) Historical PE Ratio (quarterly & annually)

How has ELDN PE Ratio performed in the past?

The mean historical PE Ratio of Eledon Pharmaceuticals, Inc. over the last ten years is -1.53. The current -5.09 PE Ratio has changed 33.07% with respect to the historical average. Over the past ten years (40 quarters), ELDN's PE Ratio was at its highest in in the September 2024 quarter at 0.59. The PE Ratio was at its lowest in in the March 2025 quarter at -10.07.

Quarterly (TTM)
Annual

Average

-1.53

Median

-0.96

Minimum

-5.49

Maximum

-0.37

Eledon Pharmaceuticals, Inc. (ELDN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Eledon Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.34%

Maximum Annual PE Ratio = -0.37

Minimum Annual Increase = -90.84%

Minimum Annual PE Ratio = -5.49

Quarterly (TTM)
Annual
YearPE RatioChange
2025-2.70-50.91%
2024-5.491.34%
2023-0.382.82%
2022-0.37-80.44%
2021-1.89110.90%
2020-0.90109.92%
2019-0.43-58.27%
2018-1.02-41.96%
2017-1.77344.00%
2016-0.40-90.84%

Eledon Pharmaceuticals, Inc. (ELDN) Average PE Ratio

How has ELDN PE Ratio performed in the past?

The current PE Ratio of Eledon Pharmaceuticals, Inc. (ELDN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-2.86

5-year avg

-2.17

10-year avg

-1.53

Eledon Pharmaceuticals, Inc. (ELDN) PE Ratio vs. Peers

How is ELDN’s PE Ratio compared to its peers?

Eledon Pharmaceuticals, Inc.’s PE Ratio is less than Puma Biotechnology, Inc. (15.24), less than Abeona Therapeutics Inc. (4.49), less than Allogene Therapeutics, Inc. (-2.60), less than Vanda Pharmaceuticals Inc. (-1.43), less than Atea Pharmaceuticals, Inc. (-2.07), less than Voyager Therapeutics, Inc. (-1.88), less than Entrada Therapeutics, Inc. (-1.77), less than Humacyte, Inc. (-1.57), less than Achieve Life Sciences, Inc. (-4.33), less than Editas Medicine, Inc. (-2.19),

Build a custom stock screener for Eledon Pharmaceuticals, Inc. (ELDN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eledon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eledon Pharmaceuticals, Inc. (ELDN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eledon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Eledon Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the highest PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the 3-year average PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the 5-year average PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?

How does the current PE Ratio for Eledon Pharmaceuticals, Inc. (ELDN) compare to its historical average?